These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15015635)

  • 21. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells.
    Eickhoff B; Rüller S; Laue T; Köhler G; Stahl C; Schlaak M; van der Bosch J
    Biol Chem; 2000 Feb; 381(2):107-12. PubMed ID: 10746741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
    Lee KJ; Lee KY; Lee YM
    Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
    Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
    Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination Treatment of p53-Null HL-60 cells with Histone Deacetylase Inhibitors and Chlorambucil Augments Apoptosis and Increases BCL6 and p21 Gene Expression.
    Kwa FAA; Cole-Sinclair MF; Kapuscinski MK
    Curr Mol Pharmacol; 2019; 12(1):72-81. PubMed ID: 30318011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
    Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells.
    Zhang S; Zhang QC; Jiang SJ
    Chin Med J (Engl); 2013 Jan; 126(1):129-34. PubMed ID: 23286491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells.
    Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E
    Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
    Flørenes VA; Skrede M; Jørgensen K; Nesland JM
    Melanoma Res; 2004 Jun; 14(3):173-81. PubMed ID: 15179185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
    Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
    Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
    Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Bertacca G; Chella A; Merlo G; Angeletti CA; Dalla Palma P; Bevilacqua G
    Oncogene; 1996 Mar; 12(6):1319-24. PubMed ID: 8649834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
    Chang TH; Szabo E
    Clin Cancer Res; 2002 Apr; 8(4):1206-12. PubMed ID: 11948134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition of A549 human lung adenocarcinoma cells by L-canavanine is associated with p21/WAF1 induction.
    Ding Y; Matsukawa Y; OhtaniFujita N; Kato D; Dao S; Fujii T; Naito Y; Yoshikawa T; Sakai T; Rosenthal GA
    Jpn J Cancer Res; 1999 Jan; 90(1):69-74. PubMed ID: 10076567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
    Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
    Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo.
    Sasakawa Y; Naoe Y; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
    Cancer Lett; 2003 Jun; 195(2):161-8. PubMed ID: 12767524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
    Noh EJ; Lee JS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.